Literature DB >> 349102

Immunofluorescent patterns in the idiopathic interstitial pneumonias.

M I Schwarz, R B Dreisin, D S Pratt, R E Stanford.   

Abstract

Immunologic mechanisms have been implicated in the pathogenesis of the IIP's. Thirty five patients with IIP were divided into three groups: group I, seven subjects with DIP; group II, thirteen with UIP; and group III, fifteen with mural fibrosis. Lung biopsies were exposed to fluorescein-conjugated antisera to IgG, IgA, IgE, IgM, C3, fibrinogen, and albumin. In group I, all patients demonstrated IgG and C3 in a granular pattern lining alveolar walls. Similarly, in group II, all had IgG and 10 had C3 within alveolar walls. In contrast, only two group III subjects demonstrated IgG and none C3. Only one of 19 control subjects hav alveolar wall immunoglobulin and C3 deposition. The incidence of positive rheumatoid and antinuclear factors was similar in all three study groups. These data suggest that immune complex deposition may play a role in the pathogenesis of the cellular interstitial pneumonias and that once mural fibrosis supervenes, these complexes are no longer present.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 349102

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

1.  Rapidly fatal pulmonary fibrosis: the accelerated variant of interstitial pneumonitis.

Authors:  D S Pratt; M I Schwartz; J J May; R B Dreisin
Journal:  Thorax       Date:  1979-10       Impact factor: 9.139

2.  Idiopathic pulmonary fibrosis.

Authors:  M I Schwarz
Journal:  West J Med       Date:  1988-08

3.  A new experimental model of in-situ immune complex disease of the lung.

Authors:  N W Boyce; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

4.  Time course of bleomycin-induced lung fibrosis.

Authors:  G Izbicki; M J Segel; T G Christensen; M W Conner; R Breuer
Journal:  Int J Exp Pathol       Date:  2002-06       Impact factor: 1.925

5.  Detection of anti-cytokeratin 8 antibody in the serum of patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders.

Authors:  N Dobashi; J Fujita; Y Ohtsuki; I Yamadori; T Yoshinouchi; T Kamei; M Tokuda; S Hojo; H Okada; J Takahara
Journal:  Thorax       Date:  1998-11       Impact factor: 9.139

Review 6.  The ultrastructure of human fibrosing alveolitis.

Authors:  J J Coalson
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

7.  Immunohistological study of human lungs by immunoperoxidase technique.

Authors:  B Fox; S Shousha; K R James; G C Miller
Journal:  J Clin Pathol       Date:  1982-02       Impact factor: 3.411

8.  Acute lung injury in rat caused by immunoglobulin A immune complexes.

Authors:  K J Johnson; B S Wilson; G O Till; P A Ward
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.

Authors:  W A Wallace; S N Roberts; H Caldwell; E Thornton; A P Greening; D Lamb; S E Howie
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

10.  Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis.

Authors:  W A Wallace; J A Schofield; D Lamb; S E Howie
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.